Literature DB >> 6804569

The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.

P A Marino, D O Adams.   

Abstract

The capacity for augmented binding of tumor cells is an initial and necessary part of macrophage-mediated tumor cytotoxicity. To study the induction of binding capacity, we obtained FCS-elicited, inflammatory macrophages from C57BL/6J mice. Exposure of these macrophages to lymphokine(s) containing MAF induced augmented binding capacity in a dose-dependent fashion. Resident peritoneal macrophages did not respond to lymphokine, and endotoxin did not appreciably influence induction of binding. Maximum induction of binding required continuous interaction between macrophages and lymphokine for 6 to 10 hr. The conditions necessary for induction of binding closely paralleled those for induction of priming or cytolysis. Exposure of FCS-elicited macrophages from C3H/HeJ mice, although not of macrophages from A/J mice, induced augmented binding. The data suggest that the augmented capacity for binding tumor cells is induced by lymphokine(s) and that a major part of induction of priming for cytolysis by MAF is induction of such binding.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6804569

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Effects of L2C leukemia on macrophage-mediated responses.

Authors:  D P Collins
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Modulation of monocyte complement synthesis by interferons.

Authors:  A O Hamilton; L Jones; L Morrison; K Whaley
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

3.  The effect of adherence on the in vitro induction of cytocidal activity by macrophages.

Authors:  A Friedman; D I Beller
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

4.  Transforming growth factor-beta 1 inhibits activation of macrophage cell line RAW 264.7 for cell killing.

Authors:  M Haak-Frendscho; T A Wynn; C J Czuprynski; D Paulnock
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

5.  Interaction of high or low metastatic related tumor lines with normal or lymphokine-activated syngeneic peritoneal macrophages: in vitro analysis of tumor cell binding and cytostasis.

Authors:  V Schirrmacher; B Appelhans
Journal:  Clin Exp Metastasis       Date:  1985 Jan-Mar       Impact factor: 5.150

6.  Ontogeny of 'macrophage' function. IV. Newborn mouse macrophages strongly suppress tumour cell growth and readily acquire cytolytic activity in comparison with adult macrophages.

Authors:  M Ido; K Uno; K Inaba; Y Aotsuka; S Muramatsu
Journal:  Immunology       Date:  1984-06       Impact factor: 7.397

7.  Demonstration and partial characterization of the interferon-gamma receptor on human mononuclear phagocytes.

Authors:  A Celada; R Allen; I Esparza; P W Gray; R D Schreiber
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

8.  Role of culture supernatant of cytotoxic/cytostatic macrophages in activation of murine resident peritoneal macrophages.

Authors:  S Hashimoto; M Nagaoka; K Hayashi; T Yokokura; M Mutai
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

9.  Human lymphokine preparations which generate tumoricidal properties of human monocytes in vitro may be distinct from gamma interferon.

Authors:  E S Kleinerman; R H Wiltrout; R Zicht; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.